Systemic inflammation, endothelial dysfunction, dietary fatty acids and micronutrients as risk factors for stroke: A selective review

Cerebrovascular Diseases

Volumn 13, Issue 4, 2002, Pages 219-224

  Feigin, Valery L ^a   Anderson, Craig S ^a   Mhurchu, Cliona Ni ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Dietary fatty acids; Endothelial dysfunction; Micronutrients; Review; Risk factors; Stroke; Systemic inflammation

Indexed keywords

ARYLDIALKYLPHOSPHATASE; C REACTIVE PROTEIN; HOMOCYSTINE; TRACE ELEMENT; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER; EDIBLE OIL;

AGE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE MARKER; ENDOTHELIUM LESION; ENZYME ACTIVITY; FAT INTAKE; HUMAN; INFLAMMATION; PREDICTION; PRIORITY JOURNAL; REVIEW; STROKE; BLOOD; CEREBROVASCULAR ACCIDENT; PATHOPHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; DIETARY FATS, UNSATURATED; ENDOTHELIUM, VASCULAR; HUMAN; INFLAMMATION; MICRONUTRIENTS; RISK FACTORS; HUMANS;

EID: 0036000299     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057846     Document Type: Review

References (87)

1. Mortality by cause for eight regions of the world: Global burden of disease study
2. Stroke
3. Predicting survival for one year among different subtypes of stroke. Results from the Perth Community Stroke study
4. Predicting survival after stroke: A three-year follow-up
5. A population-based assessment of the impact and burden of caring for long-term survivors of stroke
6. Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth Population-Based Stroke Registers
7. Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-91
8. Early management and outcome of acute stroke in Auckland
9. Environmental factors and stroke. A selective review
10. Primary prevention of stroke
11. An evaluation of the epidemiology of atherothrombotic brain infarction
12. Atherosclerosis is an inflammatory disease
13. Plaque disruption and thrombosis. Potential role of inflammation and infection
14. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
15. Heterozygous osteopetrotic mutation reduces atherosclerosis in ldl receptor-deficient mice
16. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
17. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
18. Circulating markers of inflammation for vascular risk prediction: Are they ready for prime time
19. Chronic infections and coronary heart disease: Is there a link?
20. Smoldering arteries? Low-grade inflammation and coronary heart disease
21. Atherosclerosis - An inflammatory disease
22. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
23. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project
24. Fibrinogen and risk of cardiovascular disease. The Framingham study
25. Helicobacter pylori infection and early onset myocardial infarction: Case-control and sibling pairs study
26. Fibrinogen and cerebrovascular disease
27. Inflammation, pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
28. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
29. Effect of short-term aspirin use on C-reactive protein
30. Endothelial dysfunction in cardiovascular disease: Risk factor, risk marker, or surrogate end point?
31. Endothelium-dependent and -independent functions are impaired in patients with coronary heart disease
32. The endothelium: A new target for therapy
33. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
34. Endothelial dysfunction in hypertension: Fact or fancy?
35. Endothelial dysfunction in human disease
36. Endothelial dysfunction: From physiology to therapy
37. Coronary risk factors, endothelial function and atherosclerosis: A review
38. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein
39. Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine-induced endothelial damage?
40. Lipid peroxidation in homocysteinaemia
41. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
42. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis
43. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
44. Homocysteinemia: Role in vascular diseases
45. Von Willebrand factor: A marker of endothelial dysfunction in vascular disorders?
46. The molecular mechanism of platelet adhesion
47. Von Willebrand factor and its relevance to cardiovascular disorders
48. Von Willebrand factor and pulmonary endothelial dysfunction. Prognostic implications
49. Haemostatic risk factors for cardiovascular diseases
50. Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease
51. Von Willebrand factor and risk of ischemic stroke
52. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants
53. Von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality
54. Hematologic causes of intracerebral hemorrhage and their treatment
55. Von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia
56. Von Willebrand factor and endothelial damage in essential hypertension
57. Prospective study of markers of hemostatic function with risk of ischemic stroke
58. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery study
59. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI Prevenzione Trial
60. Fish oil and cardiovascular disease: Lipids and arterial function
61. Dietary fatty acids - The N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan
62. Inverse association of dietary fat with development of ischemic stroke in men
63. Fish consumption and cardiovascular disease in the Physicians' Health Study: A prospective study
64. Intake of fish and omega-3 fatty acids and risk of stroke in women
65. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART)
66. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart study
67. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI Prevenzione Trial
68. Micronutrients, dietary questionnaires and cancer
69. Antioxidants, nutritional supplements and life-threatening diseases
70. Micronutrients and cancer aetiology: The epidemiological evidence
71. Fruit and vegetable intake in relation to risk of ischemic stroke
72. Fruit and vegetables, and cardiovascular disease: A review
73. A clinical trial of the effects of dietary patterns on blood pressure
74. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey
75. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins
76. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis
77. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (Apo) A-I with severe hypercholesterolaemia
78. Vitamin E: The evidence for an anti-atherogenic role
79. Selenium in biology
80. Zinc and Alzheimer's disease: Is there a direct link?
81. Selenium
82. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: An epidemiological update with special attention to carotene and vitamin C
83. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective study
84. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk Prospective Study: A prospective population study
85. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States
86. Vitamin E supplementation and cardiovascular events in high-risk patients